# PREDICT-PVI Understanding Peripheral Restenosis: Genomic and Proteomic Determinants of Vascular Intervention

> **NCT02180373** · — · COMPLETED · sponsor: **Vascular Cures** · enrollment: 67 (actual)

## Conditions studied

- Peripheral Artery Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02180373
- **Lead sponsor:** Vascular Cures
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12
- **Primary completion:** 2017-07-28
- **Final completion:** 2017-07-28
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2021-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02180373

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02180373, "PREDICT-PVI Understanding Peripheral Restenosis: Genomic and Proteomic Determinants of Vascular Intervention". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02180373. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*